These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Electroconvulsive therapy and transcranial magnetic stimulation: can they be considered valid modalities in the treatment of pediatric mood disorders? Stein D; Weizman A; Bloch Y Child Adolesc Psychiatr Clin N Am; 2006 Oct; 15(4):1035-56, xi. PubMed ID: 16952774 [TBL] [Abstract][Full Text] [Related]
3. [For and against: broader indication of electroconvulsive therapy]. Regen F; Bajbouj M; Anghelescu I; Folkerts H Psychiatr Prax; 2005 Nov; 32(8):378-80. PubMed ID: 16308800 [No Abstract] [Full Text] [Related]
4. Should caffeine become the first-line treatment for postdural puncture headache? Baumgarten RK Anesth Analg; 1987 Sep; 66(9):913-4. PubMed ID: 3619102 [No Abstract] [Full Text] [Related]
5. Introducing the expert electroconvulsive therapy physician for 2009: one person's reflection. McCall WV J ECT; 2009 Sep; 25(3):155-6. PubMed ID: 19730027 [No Abstract] [Full Text] [Related]
6. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study. Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624 [TBL] [Abstract][Full Text] [Related]
7. [A new analgesic in pediatric practice: Sig 8304]. Rosaschino F; Cosentina R; Castelli F; Milone V; Bosco U Clin Ter; 1986 Jun; 117(6):469-73. PubMed ID: 3742968 [No Abstract] [Full Text] [Related]
8. [Stability and anti-inflammatory action of an injection solution of sodium salicylate with sodium caffeine-benzoate]. Rybachuk DV; Drohovoz SM; Spesyvtseva ZS; Berezniakova AI; Koniev FA Farm Zh; 1979; (6):44-6. PubMed ID: 520523 [No Abstract] [Full Text] [Related]
9. [Effect of caffeine and caffeine benzoate on the DNA damage in irradiated cultured cells]. Veksler FB; Eĭdus LKh; Veksler AM Radiobiologiia; 1980; 20(4):598-602. PubMed ID: 7413949 [No Abstract] [Full Text] [Related]
10. Practitioner review: electroconvulsive therapy in adolescents. Walter G; Rey JM; Mitchell PB J Child Psychol Psychiatry; 1999 Mar; 40(3):325-34. PubMed ID: 10190334 [TBL] [Abstract][Full Text] [Related]
11. Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine. Beale MD; Pritchett JT; Kellner CH Convuls Ther; 1994 Sep; 10(3):228-31. PubMed ID: 7834261 [TBL] [Abstract][Full Text] [Related]
12. Use of complementary and alternative medicine among individuals with serious mood disorders receiving electroconvulsive therapy. Keaton D; Lamkin N; Cassidy KA; Meyer WJ; Ignacio RV; Aulakh L; Blow FC; Sajatovic M J ECT; 2009 Sep; 25(3):221. PubMed ID: 19730030 [No Abstract] [Full Text] [Related]
13. [Optimization of electroconvulsive therapy. Strategies for an adequate convulsion: role of caffeine]. Navinés R; Bernardo M; Martínez-Pallí G; Blanch J; Salvà J Actas Esp Psiquiatr; 2000; 28(3):194-201. PubMed ID: 11000702 [TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy in the 1980s. Major LF Psychiatr Clin North Am; 1984 Sep; 7(3):611-23. PubMed ID: 6483655 [TBL] [Abstract][Full Text] [Related]
15. [Effect of barbital sodium and caffeine sodium benzoate on conditioned reflex in the rat]. BATTIG K; GRANDJEAN E Helv Physiol Pharmacol Acta; 1955; 13(4):C54-5. PubMed ID: 13306119 [No Abstract] [Full Text] [Related]
16. ECT for the treatment of mood disorders in cancer patients. Beale MD; Kellner CH; Parsons PJ Convuls Ther; 1997 Dec; 13(4):222-6. PubMed ID: 9437566 [TBL] [Abstract][Full Text] [Related]
17. [Benzoate-caffeine interaction]. Lajos B Acta Pharm Hung; 1976 Nov; 46(5-6):177-82. PubMed ID: 1020640 [No Abstract] [Full Text] [Related]
18. New technology in convulsive therapy: a challenge in training. Fink M Am J Psychiatry; 1987 Sep; 144(9):1195-8. PubMed ID: 3631317 [No Abstract] [Full Text] [Related]
19. [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity]. van Waarde JA; Stek ML Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1693-7. PubMed ID: 11561488 [TBL] [Abstract][Full Text] [Related]